MD4763C1 - Compoziţie farmaceutică - Google Patents
Compoziţie farmaceuticăInfo
- Publication number
- MD4763C1 MD4763C1 MDA20180049A MD20180049A MD4763C1 MD 4763 C1 MD4763 C1 MD 4763C1 MD A20180049 A MDA20180049 A MD A20180049A MD 20180049 A MD20180049 A MD 20180049A MD 4763 C1 MD4763 C1 MD 4763C1
- Authority
- MD
- Moldova
- Prior art keywords
- pharmaceutical composition
- levocarnitine
- consequences
- injections
- medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Abstract
Invenţia se referă la medicină, şi anume la remedii pentru tratamentul bolii ischemice a cordului şi a consecinţelor ei.Compoziţia farmaceutică conţine hidroclorură de arginină, levocarnitină şi apă pentru injecţii.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201511330U UA106905U (uk) | 2015-11-17 | 2015-11-17 | Фармацевтична композиція |
UAA201611435A UA119768C2 (uk) | 2016-11-11 | 2016-11-11 | Фармацевтична композиція |
PCT/IB2016/056901 WO2017085642A1 (ru) | 2015-11-17 | 2016-11-16 | Фармацевтическая композиция |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20180049A2 MD20180049A2 (ro) | 2018-09-30 |
MD4763B1 MD4763B1 (ro) | 2021-08-31 |
MD4763C1 true MD4763C1 (ro) | 2022-03-31 |
Family
ID=58718454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20180049A MD4763C1 (ro) | 2015-11-17 | 2016-11-16 | Compoziţie farmaceutică |
Country Status (2)
Country | Link |
---|---|
MD (1) | MD4763C1 (ro) |
WO (1) | WO2017085642A1 (ro) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022018707A1 (en) * | 2020-07-24 | 2022-01-27 | M.T.K. Medical Center Limited Liability Company | Infusion solution comprising arginine hydrochloride and levocarnitine for treatment and prevention of diseases in pregnant women and promotion of fetal development during pregnancy |
UA126094C2 (uk) * | 2020-07-24 | 2022-08-10 | Тов "Медичний Центр "М.Т.К." | Застосування розчину для інфузій для лікування захворювань, пов'язаних із порушеннями мозкового кровообігу |
WO2022018705A1 (en) * | 2020-07-24 | 2022-01-27 | M.T.K. Medical Center Limited Liability Company | A pharmaceutical composition for treating cardiovascular and cerebrovascular disorders,diseases in pregnant women and improving exercise tolerance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101336914B (zh) * | 2007-07-03 | 2011-12-28 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种缩小心肌梗死面积的药物组合物及其应用 |
CN103948581B (zh) * | 2014-02-26 | 2018-05-08 | 青岛大学医学院附属医院 | 左卡尼汀联合l-精氨酸在制备治疗糖尿病视网膜病变神经损伤药物中的应用 |
-
2016
- 2016-11-16 WO PCT/IB2016/056901 patent/WO2017085642A1/ru active Application Filing
- 2016-11-16 MD MDA20180049A patent/MD4763C1/ro active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2017085642A1 (ru) | 2017-05-26 |
MD20180049A2 (ro) | 2018-09-30 |
MD4763B1 (ro) | 2021-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20210109A1 (ar) | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك | |
PH12018500569A1 (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
PH12017500571A1 (en) | Mono-or di-substituted indole derivatives as dengue viral replication inhibitors | |
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
PH12017501272A1 (en) | Indole derivatives as dengue viral replication inhibitors | |
JOP20160198B1 (ar) | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك | |
CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
PH12019501018A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
MD4763C1 (ro) | Compoziţie farmaceutică | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
EA201691796A1 (ru) | П-замещенные асимметричные мочевины и их применение в медицине | |
MX2017006747A (es) | Amidas de acidos grasos para la prevencion y/o tratamiento de la esteatohepatitis. | |
TR201903234T4 (tr) | Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti. | |
MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
MY185672A (en) | Mono-or di-substituted indole derivatives as dengue viral replication inhibitors | |
MY197383A (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
MD20150017A2 (ro) | Utilizarea preparatului Polibiolin la pacienţii cu ciroză hepatică | |
LV15072A (lv) | Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai | |
BR112017003900A2 (pt) | formulações de testosterona e métodos de tratamento com as mesmas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued |